Article info
PDFOvarian Cancer
Angiogenesis Inhibitors for the Treatment of Ovarian Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
- Address correspondence and reprint requests to Guiling Li, MD, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. E-mail: lgl6714{at}163.com.
Citation
Angiogenesis Inhibitors for the Treatment of Ovarian Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
Publication history
- Received July 2, 2017
- Accepted January 4, 2018
- First published June 1, 2018.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.